Home Watchlist Market News High Impact News Market Movers Screener Portfolio Calculators Heatmap Compare Calendars Crypto Forex Macro Maps

Research Tools

Financial Analysis Analyst Estimates Insider Trading Market Guide Trading Ideas Charts

Financial Analysis

Highlights Income Statement Balance Sheet Cash Flow Multiples Profitability

Loading stock research

Loading market dashboard

My Watchlist

Create an account to keep a persistent watchlist.

Home High Impact News Market Movers

Loading stock research

Korro Bio, Inc.

KRRO

HealthcareNASDAQUS

$10.72

-$0.46 (-4.11%)

Overview Financials Analysis Valuation Thesis Ownership Compare AI Report News

KRRO

1Y-0.46 (-4.11%)

Candles, volume, SMA 20, and SMA 50

O 11.09H 11.28L 10.46C 10.72Date Jun 5

KRRO

SMA 20 SMA 50 Vol 187.70KEEarnings dates

Open in Chartsfor further analysis

Business Description

Open for the full company profile when you need deeper context.

ShowHide

Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts.

Key Metrics

Quick size, liquidity, and volatility measures for the stock.

Market Cap?$106.70M

Volume?187.07K

Avg Volume?178.69K

52w Range$5.204 - $55.89

Beta?2.10

Price Performance

-16.8%

$12.89 to $10.72

YTD

+33.8%

$8.01 to $10.72

-26.5%

$14.59 to $10.72

-43.1%

$18.85 to $10.72

-97.8%

$477.50 to $10.72

10Y

N/A

history unavailable

Company Details

CEO, industry, employees, IPO date, currency, and website.

ShowHide

CEORam Aiyar

IndustryBiotechnology

Employees112

IPO Date2019-10-03

CurrencyUSD

Websitewww.korrobio.com

Related stocks

Check out other names from the same Biotechnology industry as KRRO.

Amarin Corporation plc

Alto Neuroscience, Inc.

18.26USD

-8.84%

AURA-

Aura Biosciences, Inc.

6.63USD

-2.50%

DBVT-

DBV Technologies S.A.

LB Pharmaceuticals Inc Common Stock

28.53USD

-1.28%

LRMR-

Larimar Therapeutics, Inc.

3.17USD

-3.65%

SLN-

Silence Therapeutics plc

6.17USD

-9.93%